Additionally, activation of Nrf2/ARE effectively prevents diabetic cardiomyopathy [21], myocardial ischemia-reperfusion injury [22, 23], and doxorubicin-induced cardiotoxicity [24]. This evidence concerns the gene NFE2L2 and diabetic cardiomyopathy.